Global – October 21, 2026 -- Lightbeam has published a four-stage AI adoption maturity lifecycle for healthcare that projects the largest ROI at the automation stage, over an estimated five-year horizon. The framework targets healthcare CXOs struggling to build AI strategies and roadmaps amid rapid change. Lightbeam describes it as arguably the first lifecycle of its kind.
Stage 1 augmentation delivers only incremental ROI
Stage 1 covers machine learning, NLP, NLG and generative AI/LLMs applied to repetitive queries, tasks and workflows. Examples include early physician scribes, conversational chatbots and GenAI platforms such as GPT 5, Claude and Gemini. Lightbeam says the returns so far are enhanced productivity, some Full-Time Equivalent savings and higher customer satisfaction from self-service.
Stage 2 prescriptive actioning moves decision support to the point of care
Stage 2 shifts from descriptive and predictive analytics to specific, actionable recommendations at the point of care. Lightbeam says the ROI potential is considerably higher because recommendations can target revenue uplift, cost savings, customer satisfaction and employee productivity.
Stage 3 automation is where Lightbeam expects the most value
Stage 3 automates manual, repetitive and error-prone processes, with exception handling that either involves humans or runs without them. Lightbeam cites ambient clinical intelligence, which records a patient encounter, converts speech to text and passes it to the clinician for review before upload to the EHR. In supply chains, it points to automatic replenishment of life-saving drugs or devices when inventory hits a threshold.
Lightbeam expects gains from higher productivity among physicians, nurses and care managers, and from added virtual engagement capacity without extra hires. It notes that multilingual robot nurses in Japan and Thailand already carry medicines and food, take vital signs and schedule appointments. At scale, it warns, the shift could cause mass unemployment that society will need to address.
Stage 4 autonomous AI is close in radiology
Stage 4 covers systems that decide and act independently, adapting to outcomes. Lightbeam says a "Dr. AI Radiologist" is fairly close to realization. It would scan thousands of DICOM images within minutes, document findings and escalate suspected heart attack or stroke cases to a resident radiologist before routing to a neurosurgeon or interventional cardiologist.
Hackensack Meridian Health CEO Robert C. Garrett is quoted in the material saying AI and industry partnerships could "improve health for billions." Lightbeam's next post will cover artificial general intelligence, and it has announced a LinkedIn Live session titled "The Art of the Possible with AI in Healthcare."